Notice ID: 9f19fb7a619a4273b0b5f88eb7b180a4Solicitation
Biopharmaceutical Manufacturing Preparedness-Consortium (BioMaP�Consortium)
Archived on September 6, 2023. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 3:00 PM UTC−04:00
- Posted
- August 9, 2023
- Notice type
- Solicitation
- NAICS
- 325414: Biological Product (except Diagnostic) Manufacturing
- Agency
- Department of Health and Human ServicesOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Notice details
- Office
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Last updated
- Sep 9, 2025
Identifiers
- Solicitation number
- 75A50123D00003
- Notice ID
- 9f19fb7a619a4273b0b5f88eb7b180a4
Description
Note: Updated August 9, 2023 to add Amendment 1, which provides responses to questions regarding the solicitation. ------------------------------------------------------------------------------------------------------------------------ Biomedical Advanced Research and Development Authority's (BARDA) primary objective is to establish an agreement with a Consortium Management Firm (CMF) tasked to establish the BioMaP-Consortium and engage in the overall day to day management of the BioMaP-Consortium under the guidance of the BioMaP Branch of BARDA. The CMF will participate in and manage all technical, programmatic, reporting, financial, and administrative matters pertaining to the BioMaP-Consortium. The CMF will also solicit, award, and manage Project Agreements/Sub-Agreements to consortium members. Please find the full solicitation attached. All questions, notices of intent, and responses should be submitted via email to shane.sarchiapone@hhs.gov. Questions are due by 3:00 PM Eastern on August 7, 2023. Notices of intent are due by 5:00 PM Eastern on August 10, 2023. Responses are due by 3:00 PM Eastern on August 22, 2023.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75A50123D00003- Solicitation
Award typically follows within 30–90 days after the response deadline. (estimate)
- 2×SolicitationCurrentJul 31, 2023
Biopharmaceutical Manufacturing Preparedness-Consortium (BioMaP�Consortium)
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
NOTICE OF INTENT – SOLE-SOURCE ACQUISITION Notice No.: The National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS), intends to award a Firm-Fixed-Price Purchase Order to Creative Biolab Inc. for culture all cells and differentiate them, expand their cell populations to more than 20 million, collect them, verify cell count, and send them back to us. Description of the Requirement The primary objective of this study is to sequence and analyze the 4q35 locus on Chromosome 4 for several years. This locus is a gene-poor and extremely long (>100K) region of DNA that consists of many repetitive sequences which makes sequencing and analysis extremely difficult. To sequence this locus using Nanopore Sequencing technology. To expand the number of samples for our experiment, we looked for a company that can handle numerous cell lines and follow the protocol that we provide. Creative Biolabs is the only company/research institute that has been able to perform differentiation within 3 months and has the ability to follow our protocol with numerous cell lines. Justification for the Proposed Sole-Source Acquisition The Government intends to solicit from a single source pursuant to FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. Only Creative Biolabs was willing to follow our exact protocol and had the logistical capacity to handle the large number of cell lines that we need to analyze, which is vital to research at the National Institute of Environmental Health Sciences. Response Information This notice is not a request for competitive quotations or proposals. However, interested parties that believe they can meet the Government's requirements may submit a capability statement demonstrating their ability to provide the required preventive maintenance and remedial repair services for the specified instrument and meet all applicable technical and operational requirements. The Government will review timely submissions to determine whether another responsible source is capable of satisfying the requirement and whether a competitive acquisition is appropriate. The Government anticipates making an award approximately five (5) calendar days after the closing date of this notice, unless the Government determines that another responsible source can satisfy the requirement. Capability statements must be submitted electronically to verne.griffin@nih.gov no later than 9:00 a.m. EDT on November 13, 2026. Please reference Notice No. 75N98027Q00053 in the subject line of the submission. | - | Pre-Solicitation | 11/12/2026 |
SAM.gov SOURCES SOUGHT NOTICE Solicitation Number: 75N98027Q00029 Title: Tau radiotracers for Baltimore Longitudinal Study of Aging Classification Code: 6505 NAICS Code: 325414 Description: Biological Product (except Diagnostic) Manufacturing This is a Small Business Sources Sought Notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified small business sources; (2) whether they are small businesses; HUBZone small businesses; service-disabled, veteran-owned small businesses; 8(a) small businesses; veteran-owned small businesses; woman-owned small businesses; or small disadvantaged businesses; (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. An organization that is not considered a small business under the applicable NAICS code should not submit a response to this notice. This notice is issued to help determine the availability of qualified companies technically capable of meeting the Government requirement and to determine the method of acquisition. It is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice. The Government will NOT be responsible for any costs incurred by the respondents to this notice. This notice is strictly for research and information purposes only. Background: The BLSA was initiated in 1958 and is a multi-disciplinary study of physiologic and psychologic aspects of normal aging in community-dwelling men and women. Since 1994, we have been conducting a longitudinal brain imaging study of selected older adults in the BLSA to characterize individual differences in longitudinal brain changes, to investigate the extent to which these brain changes underlie individual differences in cognitive aging, to identify brain changes that may be predictors of cognitive decline and Alzheimer’s disease (AD), and to assess the impact of potential modulators of brain and cognitive aging. More recently, we have been collecting in vivo measures of brain amyloid and tau, the hallmark pathologies of AD, using PET scanning. The purpose of this acquisition is to acquire FDA- approved second generation tau PET imaging radioligand to perform in vivo Positron Emission Tomography (PET) scans to measure brain tau neuropathology in BLSA participants on a combined PET/computed tomography (CT) scanner. Purpose and Objectives: The purpose of this acquisition is to procure Tau radiotracers for the Baltimore Longitudinal Study of Aging. Project requirements: Independently, and not as an agent of the Government, the Contractor shall provide the following Lantheus products: 70 Tau radioligand doses for the base period. Catalog Number [18F]MK-6240. 70 Tau radioligand doses for option period 1. Catalog Number [18F]MK-6240. 70 Tau radioligand doses for option period 2. Catalog Number [18F]MK-6240. Anticipated period of performance: Base Year: November 18, 2026 – November 17, 2027 Option Year 1: November 18, 2027 – November 17, 2028 Option Year 2: November 18, 2028 – November 17, 2029 Requested Response: The intent of this sources sought notice is to define the procurement strategy (e.g. set-aside, sole source, unrestricted) for a solicitation that is intended to be posted soon. Interested contractors are requested to respond by (1) identifying how their proposed product meets or exceeds the project requirements listed above; and (2) providing product literature, white papers, or capability statements that demonstrate their bona fide ability to supply such an item within the time frame described above. In addition, please state your business size status and whether you are the manufacturer or authorized distributor of the item you propose. Please note that NIH is particularly interested in small business sources. If you are a small business, please state the type of small business (small business; HUBZone; service-disabled, veteran-owned; 8(a); veteran-owned; woman-owned; or small disadvantaged businesses) and your size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. The respondent must also provide their DUNS number, organization name, address, point of contact, and size and type of business (e.g., 8(a), HubZone, etc.), pursuant to the applicable NAICS code and any other information that may be helpful in developing or finalizing the acquisition requirements. The information submitted must be must be in an outline format that addresses each of the elements of the project requirements and in the capability statement /information sought paragraphs stated herein. A cover page and an executive summary may be included but is not required. The response must include the respondents’ technical and administrative points of contact, including names, titles, addresses, telephone and fax numbers, and e-mail addresses. All responses to this notice must be submitted electronically to the Contracting Officer. Facsimile responses are NOT accepted. The response must be submitted to Kevin Alvarez, Contracting Officer, at e-mail address kevin.alvarez@nih.gov. The response must be received on or before October 27, 2026, 9:00am, Eastern Time. Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a presolicitation synopsis and solicitation may be published at SAM.gov. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s). | - | Market Research | 10/27/2026 |
Annual delivery order issued on a sole-source basis from the Department of Veteran’s Affairs Glaxosmith Kline federal supply schedule for pharmaceuticals and vaccines. The specific contract number is 36F79722D0178. The delivery order will be for proprietary Fluarix and Flulaval Influenza vaccines. | - | Sole Source / J&A | Open |
Fluzone and Flublok Influenza Vaccines for the 2026-2027 Flu season. The vaccine is required to immunize embassy immunocompromised family members. | - | Sole Source / J&A | Open |
NOTICE OF INTENT TO AWARD A SOLE SOURCE This Notice of Intent is not a request for competitive proposals. This is not a solicitation or request for offers. Only one responsible source and no other supplies or services will satisfy agency requirements. The Naval Research Laboratory (NRL) intends to award a sole source purchase order to INTEGRATED DNA TECHNOLOGIES to furnish: OGLIONUCLEOTIDE CARDS The North American Industry Classification System Code (NAICS) for this requirement is 325413 with the size standard of 1250 . The Federal Supply Code (FSC) / Product Service Code (PSC) procurement is 6550 . This purchase will be made utilizing Simplified Acquisition Procedures in accordance with: Federal Acquisition Regulation (FAR) 12.201-1 for purchases not exceeding the simplified acquisition threshold of $350,000. Interested parties may identify their interests and capability to respond to this requirement within fifteen (15) calendar days of the publication of this notice. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. Information received will be considered solely for the purpose of determining whether or not to conduct a competitive procurement. A determination by the Government not to compete this proposed purchase order based upon response to this notice is solely within the discretion of the Government. No reimbursement for any cost connected with providing capability information will be provided. The point of contact is: Richard Key , email: richard.a.key2.civ@us.navy.mil. Please reference this Notice of Intent number on your correspondence and in the “Subject” line of your email. | - | Special Notice | 06/24/2026 |
Additional Details
Solicitation Number
75A50123D00003
Archive Date
Sep 6, 2023
Office Address
WASHINGTON, DC, 20515